Why Privia Health Group, Inc.’s (PRVA) Stock Is Down 17.15%
As of Thursday, August 06, Privia Health Group, Inc.’s PRVA share price has dipped by 17.15%, which has investors questioning if this is right time to buy.Jenna Brashear
Stock Evaluator: Privia Health Group, Inc. (PRVA)
Privia Health Group, Inc. PRVA
$22.40
0.93
4.33%
November 4, 2026 4:00:00 PM
EST
Volume: 2,815,388
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
NASD | DELAYED PRICE
| SECTOR | INDUSTRY |
| Health Care | Health Care Providers & Services |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with physician practices, health plans, and health systems. It also offers technology and population health tools to enhance providers’ workflows; management services organization that enable providers to focus on their patients by reducing administrative work; and single-TIN medical group that facilitates negotiating power, clinical integration, and alignment of financial incentives. In addition, the company operates accountable care organization, which engages patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect across platform to better understand the holistic needs of each patient and connect with other providers to address individual medical needs. Further, it offers clinical services, data analytics and day-to-day operational support through preventive health and data-driven coordination, it helps practices elevate the quality of patient care and increase patient engagement. The company was founded in 2007 and is headquartered in Arlington, Virginia.
Commentary & Analysis
Why Privia Health Group, Inc.’s (PRVA) Stock Is Down 13.65%
As of Thursday, August 06, Privia Health Group, Inc.’s PRVA share price has dipped by 13.65%, which has investors questioning if this is right time to buy.Omar Beirat
What You Need to Know About Privia Health Group, Inc.'s Q3 Earnings
Privia Health Group, Inc.'s fiscal Q3 earnings report was released on Thursday, August 06. Let's dive in to see if (PRVA) missed or beat analyst's expectations.Michael Rose
Is Privia Health Group, Inc. (PRVA) Overvalued?
We dive into why Privia Health Group, Inc. (PRVA) could be considered overvalued on 2026-08-03, based on AAII’s Value Score and Grade.Tudor Pop
Why Privia Health Group, Inc.’s (PRVA) Stock Is Down 6.11%
As of Thursday, May 07, Privia Health Group, Inc.’s PRVA share price has dipped by 6.11%, which has investors questioning if this is right time to buy.Rosalio Madrigal
Financial Summary
| Share Statistics | PRVA | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $2,861.2 | $2,049.0 | 59% |
|
| Shares Out (Mil) | 131.8 | 79.7 | 68% |
|
| Institutional Ownership | 99.4% | 85.9% | 88% |
|
| Float (Mil) | 108.9 | 58.3 | 62% |
|
| Beta | 0.88 | 0.78 | 52% |
|
| Avg Daily Volume (000s) | 1,105 | 661 | 71% |
|
| Price Change (52-week) |
(9.5%) | 83.6% | 41% |
|
| Growth | PRVA | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 21.0% | 10.4% | 82% |
|
| Net Income (5yr) | (6.0%) | (1.1%) | 33% |
|
| EPS (5yr) | (11.2%) | 1.2% | 21 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (17.4%) | (17.3%) | 40% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 10 | 10 | 10 | |
| Current EPS | $0.238 | $0.887 | $1.063 | |
| Month Ago EPS | $0.243 | $0.884 | $1.061 | |
| # Rev Up | 1 | 0 | 2 | |
| # Rev Down | 2 | 0 | 1 | |
| Three Months Ago EPS | $0.259 | $0.951 | $1.097 | |
| Year/Year Chg | 240.0% | 392.8% | 563.9% | |
| Financials | PRVA | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $2,358 | $1,532 | 62% |
|
| Net Income (TTM) (Mil) | $28 | $31 | 51% |
|
| EPS (TTM) | $0.227 | $0.300 | 47% |
|
| Operating Cash Flow (TTM) (Mil) | $131 | $168 | 54% |
|
| Net Cash Flow (TTM) (Mil) | $22 | $2 | 63% |
|
| Long-Term Debt (Q1) (Mil) | $7 | $394 | 26% |
|
| Enterprise Value (Q1) (Mil) | $2,188 | $2,409 | 50% |
|
| Valuation | PRVA | Industry Median |
Percentile (All Stocks) |
|
| P/B | 3.62 | 2.97 | 73% |
|
| P/E | 102.3 | 28.0 | 94% |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.2 | na |
|
| Ratios | PRVA | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 10.0% | 27.0% | 9% |
|
| Net Margin | 1.2% | 1.3% | 35% |
|
| ROA | 2.0% | 2.2% | 55% |
|
| ROE | 3.8% | 6.8% | 41% |
|
| Liabilities to Assets | 43.7% | 61.5% | 35% |
|
| F-Score | 6 | 5 | 67% |
|
Privia Health Group, Inc. did not pass any screens on 11/4/2026.
